ARGIVIT
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ARGIVIT Trademark

Serial Number: 79442994

ARGIVIT is a trademark filed by HEKİM İLAÇ MEDİKAL KOZMETİK SANAYİ VE TİCARET LİMİTED ŞİRKETİ on December 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Trademark Details

Filing Date

December 12, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations for medical purposes; chemical preparations for medical and veterinary purposes; chemical radioactive substances for medical and veterinary purposes; medicated cosmetics; dietary supplements for pharmaceutical and veterinary purposes; dietary supplements for humans and animals; nutritional supplements; medical preparations for slimming purposes; food for babies; herbs and herbal beverages adapted for medicinal purposes; dental preparations and articles: teeth filling material, dental impression material, dental adhesives and material for repairing teeth; sanitary preparations for medical use: hygienic pads, hygienic tampons; plasters, materials for dressings, diapers made of paper and textiles for babies, adults and pets; preparations for destroying vermin; herbicides, fungicides, preparations for destroying rodents; deodorants, other than for human beings or for animals; air purifying preparations; air deodorising preparations; disinfectants; antiseptics; detergents for medical purposes; medicated soaps; disinfectant soaps; antibacterial hand lotions.

Filing History

REFUSAL PROCESSED BY IB
Jun 11, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 28, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 28, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 17, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 16, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 8, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 5, 2026 REPR